Pathogenesis and pathophysiology of bacterial infections

Infections of the Central Nervous System: Fourth Edition

Volumn , Issue , 2014, Pages

  Agyeman, Philipp ^a   Grandgirard, Denis ^a   Leib, Stephen L ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b SPIEZ LABORATORY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84908591066     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (446)

1. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364:2016-2025.
2. Nicolosi A, Hauser WA, Musicco M, et al. Incidence and prognosis of brain abscess in a defined population: Olmsted County, Minnesota, 1935-1981. Neuroepidemiology. 1991;10:122-131.
3. King N. Brain abscess. Handb Clin Neurol. 2010;96:65-74.
4. Lagu T, Rothberg MB, Shieh MS, et al. What is the best method for estimating the burden of severe sepsis in the United States? J Crit Care. 2012;27:414.e1-414.e9.
5. Nelson AL, Roche AM, Gould JM, et al. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun. 2007;75:83-90.
6. Mook-Kanamori BB, Geldhoff M, van der Poll T, et al. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24:557-591.
7. Steinfort C, Wilson R, Mitchell T, et al. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun. 1989;57: 2006-2013.
8. Hirst RA, Sikand KS, Rutman A, et al. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect Immun. 2000;68:1557-1562.
9. Kadioglu A, Taylor S, Iannelli F, et al. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun. 2002;70: 2886-2890.
10. Rao VK, Krasan GP, Hendrixson DR, et al. Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev. 1999;23:99-129.
11. Merz AJ, So M. Interactions of pathogenic neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol. 2000;16:423-457.
12. Wani JH, Gilbert JV, Plaut AG, et al. Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun. 1996;64:3967-3974.
13. Vitovski S, Read RC, Sayers JR. Invasive isolates of Neisseria meningitidis possess enhanced immunoglobulin A1 protease activity compared to colonizing strains. Faseb J. 1999;13:331-337.
14. Callewaert L, Van Herreweghe JM, Vanderkelen L, et al. Guards of the great wall: bacterial lysozyme inhibitors. Trends Microbiol. 2012;20: 501-510.
15. Boneca IG, Dussurget O, Cabanes D, et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc Natl Acad Sci U S A. 2007;104:997-1002.
16. Davis KM, Weiser JN. Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect Immun. 2011;79:562-570.
17. Davis KM, Akinbi HT, Standish AJ, et al. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathog. 2008;4:e1000241.
18. Bergmann S, Hammerschmidt S. Versatility of pneumococcal surface proteins. Microbiology. 2006;152:295-303.
19. Pizarro-Cerda J, Cossart P. Bacterial adhesion and entry into host cells. Cell. 2006;124:715-727.
20. Proft T, Baker EN. Pili in Gram-negative and Gram-positive bacteria-structure, assembly and their role in disease. Cell Mol Life Sci. 2009;66:613-635.
21. Weiser JN, Austrian R, Sreenivasan PK, et al. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun. 1994;62:2582-2589.
22. Kim JO, Weiser JN. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis. 1998;177:368-377.
23. Hammerschmidt S. Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol. 2006;9:12-20.
24. King SJ. Pneumococcal modification of host sugars: a major contributor to colonization of the human airway? Mol Oral Microbiol. 2010;25:15-24.
25. Brittan JL, Buckeridge TJ, Finn A, et al. Pneumococcal neuraminidase A: an essential upper airway colonization factor for Streptococcus pneumoniae. Mol Oral Microbiol. 2012;27:270-283.
26. Parker D, Soong G, Planet P, et al. The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun. 2009;77:3722-3730.
27. Shakhnovich EA, King SJ, Weiser JN. Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract. Infect Immun. 2002;70:7161-7164.
28. Rosenow C, Ryan P, Weiser JN, et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol. 1997;25:819-829.
29. Cundell DR, Gerard NP, Gerard C, et al. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 1995;377:435-438.
30. Grigg J. The platelet activating factor receptor: a new anti-infective target in respiratory disease? Thorax. 2012;67:840-841.
31. Bonazzi M, Cossart P. Impenetrable barriers or entry portals? The role of cell-cell adhesion during infection. J Cell Biol. 2011;195:349-358.
32. Anderton JM, Rajam G, Romero-Steiner S, et al. E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae. Microb Pathog. 2007;42:225-236.
33. Crain MJ, Waltman WD II, Turner JS, et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun. 1990;58:3293-3299.
34. Zhang Q, Bernatoniene J, Bagrade L, et al. Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status. Eur J Immunol. 2006;36:46-57.
35. Lebon A, Verkaik NJ, Labout JA, et al. Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study. Infect Immun. 2011;79:1680-1687.
36. Deghmane AE, Giorgini D, Larribe M, et al. Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol. 2002;43:1555-1564.
37. Gray-Owen SD. Neisserial Opa proteins: impact on colonization, dissemination and immunity. Scand J Infect Dis. 2003;35:614-618.
38. Rowe HA, Griffiths NJ, Hill DJ, et al. Co-ordinate action of bacterial adhesins and human carcinoembryonic antigen receptors in enhanced cellular invasion by capsulate serum resistant Neisseria meningitidis. Cell Microbiol. 2007;9:154-168.
39. St Geme JW III, Cutter D. Influence of pili, fibrils, and capsule on in vitro adherence by Haemophilus influenzae type b. Mol Microbiol. 1996;21:21-31.
40. Weber A, Harris K, Lohrke S, et al. Inability to express fimbriae results in impaired ability of Haemophilus influenzae b to colonize the nasopharynx. Infect Immun. 1991;59:4724-4728.
41. Cotter SE, Yeo HJ, Juehne T, et al. Architecture and adhesive activity of the Haemophilus influenzae Hsf adhesin. J Bacteriol. 2005;187:4656-4664.
42. Hill DJ, Toleman MA, Evans DJ, et al. The variable P5 proteins of typeable and non-typeable Haemophilus influenzae target human CEACAM1. Mol Microbiol. 2001;39:850-862.
43. Avadhanula V, Rodriguez CA, Ulett GC, et al. Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression. Infect Immun. 2006;74:830-838.
44. Posfay-Barbe KM, Wald ER. Listeriosis. Semin Fetal Neonatal Med. 2009;14:228-233.
45. Le Bouguenec C. Adhesins and invasins of pathogenic Escherichia coli. Int J Med Microbiol. 2005;295:471-478.
46. Sokurenko EV, Chesnokova V, Dykhuizen DE, et al. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A. 1998;95:8922-8926.
47. Antao EM, Wieler LH, Ewers C. Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog. 2009;1:22.
48. Bonacorsi S, Bingen E. Molecular epidemiology of Escherichia coli causing neonatal meningitis. Int J Med Microbiol. 2005;295:373-381.
49. Kim KS, Itabashi H, Gemski P, et al. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J Clin Invest. 1992;90:897-905.
50. Tazi A, Disson O, Bellais S, et al. The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med. 2010;207:2313-2322.
51. Maisey HC, Doran KS, Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med. 2008;10:e27.
52. Rinaudo CD, Rosini R, Galeotti CL, et al. Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus. PLoS One. 2010;5:e9216.
53. Mengaud J, Ohayon H, Gounon P, et al. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell. 1996;84:923-932.
54. Lecuit M. Understanding how Listeria monocytogenes targets and crosses host barriers. Clin Microbiol Infect. 2005;11:430-436.
55. Pentecost M, Otto G, Theriot JA, et al. Listeria monocytogenes invades the epithelial junctions at sites of cell extrusion. PLoS Pathog. 2006;2:e3.
56. Nikitas G, Deschamps C, Disson O, et al. Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med. 2011;208:2263-2277.
57. Lecuit M, Nelson DM, Smith SD, et al. Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin. Proc Natl Acad Sci U S A. 2004;101:6152-6157.
58. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571-582.
59. Avadhanula V, Rodriguez CA, Devincenzo JP, et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species-and cell type-dependent manner. J Virol. 2006;80:1629-1636.
60. Greenwood BM. The epidemiology of acute bacterial meningitis in tropical Africa. Bacterial meningitis. In: Williams JD, Burnie J, eds. Bacterial Meningitis. London: Academic Press; 1987:61-91.
61. Albiger B, Johansson L, Jonsson AB. Lipooligosaccharide-deficient Neisseria meningitidis shows altered pilus-associated characteristics. Infect Immun. 2003;71:155-162.
62. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. 2003;422:37-44.
63. Veiga E, Guttman JA, Bonazzi M, et al. Invasive and adherent bacterial pathogens co-Opt host clathrin for infection. Cell Host Microbe. 2007;2:340-351.
64. Clarke TB, Francella N, Huegel A, et al. Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe. 2011;9:404-414.
65. Zwijnenburg PJ, van der Poll T, Florquin S, et al. Experimental pneumococcal meningitis in mice: a model of intranasal infection. J Infect Dis. 2001;183:1143-1146.
66. Hirst RA, Kadioglu A, O'Callaghan C, et al. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol. 2004;138:195-201.
67. Attali C, Durmort C, Vernet T, et al. The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect Immun. 2008;76:5350-5356.
68. Soriani M, Santi I, Taddei A, et al. Group B Streptococcus crosses human epithelial cells by a paracellular route. J Infect Dis. 2006;193:241-250.
69. Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol. 1994;12:63-84.
70. Zhang JR, Mostov KE, Lamm ME, et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell. 2000;102:827-837.
71. Elm C, Braathen R, Bergmann S, et al. Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem. 2004;279:6296-6304.
72. Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol. 2006;6:433-446.
73. Sadarangani M, Pollard AJ, Gray-Owen SD. Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria. FEMS Microbiol Rev. 2011;35:498-514.
74. Griffiths NJ, Bradley CJ, Heyderman RS, et al. IFN-gamma amplifies NFkappaB-dependent Neisseria meningitidis invasion of epithelial cells via specific upregulation of CEA-related cell adhesion molecule 1. Cell Microbiol. 2007;9:2968-2983.
75. Disson O, Grayo S, Huillet E, et al. Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature. 2008;455: 1114-1118.
76. Fagan RP, Lambert MA, Smith SG. The hek outer membrane protein of Escherichia coli strain RS218 binds to proteoglycan and utilizes a single extracellular loop for adherence, invasion, and autoaggregation. Infect Immun. 2008;76:1135-1142.
77. Meier C, Oelschlaeger TA, Merkert H, et al. Ability of Escherichia coli isolates that cause meningitis in newborns to invade epithelial and endothelial cells. Infect Immun. 1996;64:2391-2399.
78. Carbonnelle E, Hill DJ, Morand P, et al. Meningococcal interactions with the host. Vaccine. 2009;27(suppl 2):B78-B89.
79. Virkola R, Brummer M, Rauvala H, et al. Interaction of fimbriae of Haemophilus influenzae type B with heparin-binding extracellular matrix proteins. Infect Immun. 2000;68:5696-5701.
80. Kostyukova NN, Volkova MO, Ivanova VV, et al. A study of pathogenic factors of Streptococcus pneumoniae strains causing meningitis. FEMS Immunol Med Microbiol. 1995;10:133-137.
81. Plow EF, Herren T, Redlitz A, et al. The cell biology of the plasminogen system. Faseb J. 1995;9:939-945.
82. Knaust A, Weber MV, Hammerschmidt S, et al. Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis. J Bacteriol. 2007;189:3246-3255.
83. Virkola R, Lahteenmaki K, Eberhard T, et al. Interaction of Haemophilus influenzae with the mammalian extracellular matrix. J Infect Dis. 1996;173:1137-1147.
84. Bergmann S, Rohde M, Preissner KT, et al. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration. Thromb Haemost. 2005;94:304-311.
85. Steukers L, Glorieux S, Vandekerckhove AP, et al. Diverse microbial interactions with the basement membrane barrier. Trends Microbiol. 2012;20:147-155.
86. Pron B, Boumaila C, Jaubert F, et al. Dendritic cells are early cellular targets of Listeria monocytogenes after intestinal delivery and are involved in bacterial spread in the host. Cell Microbiol. 2001;3:331-340.
87. Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058-1066.
88. Overturf GD. Indications for the immunological evaluation of patients with meningitis. Clin Infect Dis. 2003;36:189-194.
89. Dietzman DE, Fischer GW, Schoenknecht FD. Neonatal Escherichia coli septicemia-bacterial counts in blood. J Pediatr. 1974;85:128-130.
90. Adriani KS, Brouwer MC, Geldhoff M, et al. Common polymorphisms in the complement system and susceptibility to bacterial meningitis. J Infect. 2012;66:255-262.
91. Brouwer MC, de Gans J, Heckenberg SG, et al. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9:31-44.
92. Vogel U, Hammerschmidt S, Frosch M. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med Microbiol Immunol (Berl). 1996;185:81-87.
93. Hyams C, Camberlein E, Cohen JM, et al. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun. 2010;78:704-715.
94. Kilian M, Reinholdt J, Lomholt H, et al. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. Apmis. 1996;104:321-338.
95. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997;337: 970-976.
96. Li J, Glover DT, Szalai AJ, et al. PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infect Immun. 2007;75:5877-5885.
97. Rooijakkers SH, van Strijp JA. Bacterial complement evasion. Mol Immunol. 2007;44:23-32.
98. Agarwal V, Hammerschmidt S, Malm S, et al. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J Immunol. 2012;189: 3575-3584.
99. Santi I, Scarselli M, Mariani M, et al. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol Microbiol. 2007;63:754-767.
100. Zipfel PF, Skerka C, Hellwage J, et al. Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans. 2002;30: 971-978.
101. Maruvada R, Prasadarao NV, Rubens CE. Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. Faseb J. 2009;23:3967-3977.
102. Lewis LA, Carter M, Ram S. The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci. J Immunol. 2012;188:5063-5072.
103. Gossger N, Snape MD, Yu LM, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA. 2012;307:573-582.
104. Jiang HQ, Hoiseth SK, Harris SL, et al. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine. 2010;28: 6086-6093.
105. Jarva H, Jokiranta TS, Wurzner R, et al. Complement resistance mechanisms of streptococci. Mol Immunol. 2003;40:95-107.
106. Singh B, Su YC, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol. 2010;78:545-560.
107. Kolb-Maurer A, Kurzai O, Goebel W, et al. The role of human dendritic cells in meningococcal and listerial meningitis. Int J Med Microbiol. 2003;293:241-249.
108. Peppoloni S, Ricci S, Orsi CF, et al. The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia. Microbes Infect. 2010;12:990-1001.
109. Stavru F, Archambaud C, Cossart P. Cell biology and immunology of Listeria monocytogenes infections: novel insights. Immunol Rev. 2011;240:160-184.
110. Tala A, Monaco C, Nagorska K, et al. Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst. Mol Microbiol. 2011;81:1330-1342.
111. Nandoskar M, Ferrante A, Bates EJ, et al. Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin. Immunology. 1986;59:515-520.
112. Moxon ER, Murphy PA. Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc Natl Acad Sci U S A. 1978;75:1534-1536.
113. Redzic Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS. 2011;8:3.
114. Kim KS. Strategy of Escherichia coli for crossing the blood-brain barrier. J Infect Dis. 2002;186:S220-S224.
115. Moxon ER, Ostrow PT. Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J Infect Dis. 1977;135:303-307.
116. Kim KS. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol. 2008;6:625-634.
117. Orihuela CJ, Mahdavi J, Thornton J, et al. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J Clin Invest. 2009;119:1638-1646.
118. Kim BY, Kang J, Kim KS. Invasion processes of pathogenic Escherichia coli. Int J Med Microbiol. 2005;295:463-470.
119. Coureuil M, Join-Lambert O, Lecuyer H, et al. Mechanism of meningeal invasion by Neisseria meningitidis. Virulence. 2012;3:164-172.
120. Maisey HC, Hensler M, Nizet V, et al. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol. 2007;189:1464-1467.
121. Tenenbaum T, Bloier C, Adam R, et al. Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae. Infect Immun. 2005;73:4404-4409.
122. Banerjee A, Kim BJ, Carmona EM, et al. Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat Commun. 2011;2:462.
123. Drevets DA, Leenen PJ, Greenfield RA. Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev. 2004;17:323-347.
124. Nassif X, Bourdoulous S, Eugene E, et al. How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol. 2002;10:227-232.
125. Uchiyama S, Carlin AF, Khosravi A, et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med. 2009;206:1845-1852.
126. Honda Z, Ishii S, Shimizu T. Platelet-activating factor receptor. J Biochem. 2002;131:773-779.
127. Radin JN, Orihuela CJ, Murti G, et al. Beta-arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect Immun. 2005;73:7827-7835.
128. Reddy MA, Wass CA, Kim KS, et al. Involvement of focal adhesion kinase in Escherichia coli invasion of human brain microvascular endothelial cells. Infect Immun. 2000;68:6423-6430.
129. Kim KJ, Elliott SJ, Di Cello F, et al. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells. Cell Microbiol. 2003;5:245-252.
130. Unkmeir A, Latsch K, Dietrich G, et al. Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol. 2002;46:933-946.
131. Disson O, Lecuit M. Targeting of the central nervous system by Listeria monocytogenes. Virulence. 2012;3:213-221.
132. Drevets DA, Dillon MJ, Schawang JS, et al. The Ly-6Chigh monocyte subpopulation transports Listeria monocytogenes into the brain during systemic infection of mice. J Immunol. 2004;172:4418-4424.
133. Drevets DA, Jelinek TA, Freitag NE. Listeria monocytogenes-infected phagocytes can initiate central nervous system infection in mice. Infect Immun. 2001;69:1344-1350.
134. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126:1015-1025.
135. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849-1859.
136. Marra A, Brigham D. Streptococcus pneumoniae causes experimental meningitis following intranasal and otitis media infections via a nonhematogenous route. Infect Immun. 2001;69:7318-7325.
137. van Ginkel FW, McGhee JR, Watt JM, et al. Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection. Proc Natl Acad Sci U S A. 2003;100:14363-14367.
138. Sjolinder H, Jonsson AB. Olfactory nerve-a novel invasion route of Neisseria meningitidis to reach the meninges. PLoS One. 2010;5:e14034.
139. Vinchon M, Lemaitre MP, Vallee L, et al. Late shunt infection: incidence, pathogenesis, and therapeutic implications. Neuropediatrics. 2002;33:169-173.
140. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child. 1984;138:1103-1108.
141. Reichert MC, Medeiros EA, Ferraz FA. Hospital-acquired meningitis in patients undergoing craniotomy: incidence, evolution, and risk factors. Am J Infect Control. 2002;30:158-164.
142. McGirt MJ, Zaas A, Fuchs HE, et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003;36:858-862.
143. Reddy GK, Bollam P, Caldito G. Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience. World Neurosurg. 2012;78:155-163.
144. Kockro RA, Hampl JA, Jansen B, et al. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol. 2000;49:441-450.
145. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975;131:543-552.
146. Filka J, Huttova M, Tuharsky J, et al. Nosocomial meningitis in children after ventriculoperitoneal shunt insertion. Acta Paediatr. 1999;88: 576-578.
147. Del Bigio MR. Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery. 1998;42:319-325; discussion 325-326.
148. Hartford O, O'Brien L, Schofield K, et al. The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. Microbiology. 2001;147:2545-2552.
149. Williams RJ, Henderson B, Sharp LJ, et al. Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect Immun. 2002;70:6805-6810.
150. Li DQ, Lundberg F, Ljungh A. Characterization of vitronectin-binding proteins of Staphylococcus epidermidis. Curr Microbiol. 2001;42: 361-367.
151. Thurlow LR, Hanke ML, Fritz T, et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol. 2011;186:6585-6596.
152. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis. 1982;146:479-482.
153. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-1322.
154. Snowden JN, Beaver M, Smeltzer MS, et al. Biofilm-infected intracerebroventricular shunts elicit inflammation within the central nervous system. Infect Immun. 2012;80:3206-3214.
155. Vuong C, Voyich JM, Fischer ER, et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 2004;6:269-275.
156. Kristian SA, Birkenstock TA, Sauder U, et al. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis. 2008;197:1028-1035.
157. Xu KD, McFeters GA, Stewart PS. Biofilm resistance to antimicrobial agents. Microbiology. 2000;146(pt 3):547-549.
158. Bayston R, Ullas G, Ashraf W. Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro. Antimicrob Agents Chemother. 2012;56:2842-2845.
159. Reefhuis J, Honein MA, Whitney CG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003;349:435-445.
160. Lalwani AK, Cohen NL. Does meningitis after cochlear implantation remain a concern in 2011? Otol Neurotol. 2012;33:93-95.
161. Wei BP, Shepherd RK, Robins-Browne RM, et al. Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis. Otolaryngol Head Neck Surg. 2007;136:589-596.
162. Cohen NL, Hirsch BE. Current status of bacterial meningitis after cochlear implantation. Otol Neurotol. 2010;31:1325-1328.
163. Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest. 2012;122:1164-1171.
164. Pashenkov M, Teleshova N, Kouwenhoven M, et al. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J Neuroimmunol. 2002;122:106-116.
165. Engelhardt B, Coisne C. Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS. 2011;8:4.
166. Zwahlen A, Nydegger UE, Vaudaux P, et al. Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis. 1982;145:635-646.
167. Stahel PF, Frei K, Fontana A, et al. Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis. Am J Pathol. 1997;151:897-904.
168. Small PM, Täuber MG, Hackbarth CJ, et al. Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infect Immun. 1986;52:484-487.
169. Ernst JD, Decazes JM, Sande MA. Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun. 1983;41:275-279.
170. Tuomanen EI, Saukkonen K, Sande S, et al. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med. 1989;170:959-969.
171. Tuomanen E, Hengstler B, Zak O, et al. The role of complement in inflammation during experimental pneumococcal meningitis. Microb Pathog. 1986;1:15-32.
172. Rupprecht TA, Angele B, Klein M, et al. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J Immunol. 2007;178:1861-1869.
173. Goonetilleke UR, Scarborough M, Ward SA, et al. Death is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis. MBio. 2012;3
174. Oggioni MR, Trappetti C, Kadioglu A, et al. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol. 2006;61:1196-1210.
175. Orihuela CJ, Radin JN, Sublett JE, et al. Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun. 2004;72:5582-5596.
176. Molzen TE, Burghout P, Bootsma HJ, et al. Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun. 2011;79:288-297.
177. Hanamsagar R, Hanke ML, Kielian T. Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol. 2012;33:333-342.
178. Koedel U. Toll-like receptors in bacterial meningitis. Curr Top Microbiol Immunol. 2009;336:15-40.
179. Hoegen T, Tremel N, Klein M, et al. The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol. 2011;187:5440-5451.
180. Geldhoff M, Mook-Kanamori BB, Brouwer MC, et al. Genetic variation in inflammasome genes is associated with outcome in bacterial meningitis. Immunogenetics. 2013;65:9-16.
181. Sanders MS, van Well GT, Ouburg S, et al. Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors. BMC Infect Dis. 2012;12:112.
182. van Well GT, Sanders MS, Ouburg S, et al. Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis. PLoS One. 2012;7:e35837.
183. Burroughs M, Cabellos C, Prasad S, et al. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis? J Infect Dis. 1992;165(suppl 1):S82-S85.
184. Mustafa MM, Ramilo O, Saez-Llorens X, et al. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child. 1990;144:883-887.
185. Täuber MG, Moser B. Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clin Infect Dis. 1999;28:1-11; quiz 12.
186. Kastenbauer S, Angele B, Sporer B, et al. Patterns of protein expression in infectious meningitis: a cerebrospinal fluid protein array analysis. J Neuroimmunol. 2005;164:134-139.
187. Zwijnenburg PJ, van der Poll T, Roord JJ, et al. Chemotactic factors in cerebrospinal fluid during bacterial meningitis. Infect Immun. 2006;74:1445-1451.
188. Klein M, Paul R, Angele B, et al. Protein expression pattern in experimental pneumococcal meningitis. Microbes Infect. 2006;8:974-983.
189. Mogensen TH, Paludan SR, Kilian M, et al. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukoc Biol. 2006;80:267-277.
190. Fowler MI, Weller RO, Heckels JE, et al. Different meningitis-causing bacteria induce distinct inflammatory responses on interaction with cells of the human meninges. Cell Microbiol. 2004;6:555-567.
191. Tietze K, Dalpke A, Morath S, et al. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria. J Periodontal Res. 2006;41:447-454.
192. Diab A, Zhu J, Linquist L, et al. Haemophilus influenzae and Streptococcus pneumoniae induce different intracerebral mRNA cytokine patterns during the course of experimental bacterial meningitis. Clin Exp Immunol. 1997;109:233-241.
193. Kim YS, Honkaniemi J, Sharp FR, et al. Expression of proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta in the brain during experimental group B streptococcal meningitis. Brain Res Mol Brain Res. 2004;128:95-102.
194. Arvin B, Neville LF, Barone FC, et al. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev. 1996;20:445-452.
195. Tunkel AR, Wispelwey B, Scheld WM. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med. 1990;112: 610-623.
196. Mertsola J. Cytokines in the pathogenesis of bacterial meningitis. Trans R Soc Trop Med Hyg. 1991;85(suppl 1):17-18.
197. Mustafa MM, Ramilo O, Olsen KD, et al. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest. 1989;84:1253-1259.
198. Leib SL, Clements JM, Lindberg RL, et al. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 2001;124:1734-1742.
199. Barichello T, Pereira JS, Savi GD, et al. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis. J Neuroimmunol. 2011;233:12-17.
200. Koedel U, Bayerlein I, Paul R, et al. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental pneumococcal meningitis. J Infect Dis. 2000;182:1437-1445.
201. Wellmer A, Gerber J, Ragheb J, et al. Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun. 2001;69:6881-6886.
202. Tureen J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J Clin Invest. 1995;95:1086-1091.
203. Rosenberg GA, Estrada EY, Dencoff JE, et al. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 1995;703:151-155.
204. Andersson PB, Perry VH, Gordon S. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med. 1992;176:255-259.
205. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994;25:1481-1488.
206. Glabinski A, Krajewski S, Rafalowska J. Tumor necrosis factor-alpha induced pathology in the rat brain: characterization of stereotaxic injection model. Folia Neuropathol. 1998;36:52-62.
207. Candelario-Jalil E, Taheri S, Yang Y, et al. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat. J Pharmacol Exp Ther. 2007;323:488-498.
208. Friedland IR, Jafari H, Ehrett S, et al. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J Infect Dis. 1993;168:657-662.
209. Lutsar I, Friedland IR, Jafri HS, et al. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. J Antimicrob Chemother. 2003;52:651-655.
210. Costa A, Gupta R, Signorino G, et al. Activation of the NLRP3 inflammasome by group B streptococci. J Immunol. 2012;188:1953-1960.
211. Opitz B, Puschel A, Schmeck B, et al. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem. 2004;279:36426-36432.
212. Mitchell AJ, Yau B, McQuillan JA, et al. Inflammasome-dependent IFN-gamma drives pathogenesis in Streptococcus pneumoniae meningitis. J Immunol. 2012;189:4970-4980.
213. Waage A, Halstensen A, Shalaby R. Local production of tumor necrosis factor, interleukin-l, and interleukin-6 in meningococcal meningitis. J Exp Med. 1998;170:1859-1864.
214. Helminen M, Vesikari T. Interleukin-1 production in bacterial meningitis. Scand J Infect Dis. 1990;22:105-108.
215. Rusconi F, Parizzi F, Garlaschi L, et al. Interleukin 6 activity in infants and children with bacterial meningitis. The Collaborative Study on Meningitis. Pediatr Infect Dis J. 1991;10:117-121.
216. Hirano T, Akira S, Taga T, et al. Biological and clinical aspects of interleukin-6. Immunol Today. 1990;11:443-445.
217. Cohen MC, Cohen S. Cytokine function, a study in biologic diversity. Am J Clin Pathol. 1996;105:589-598.
218. Paul R, Koedel U, Winkler F, et al. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain. 2003;126:1873-1882.
219. Zwijnenburg PJ, de Bie HM, Roord JJ, et al. Chemotactic activity of CXCL5 in cerebrospinal fluid of children with bacterial meningitis. J Neuroimmunol. 2003;145:148-153.
220. Spanaus KS, Nadal D, Pfister HW, et al. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J Immunol. 1997;158:1956-1964.
221. Paris MM, Hickey SM, Trujillo M, et al. The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis. J Infect Dis. 1997;176:1239-1246.
222. Koedel U, Bernatowicz A, Frei K, et al. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J Immunol. 1996;157:5185-5191.
223. Zwijnenburg PJG, van der Poll T, Florquin S, et al. Interleukin-10 negatively regulates local cytokine and chemokine production but does not influence antibacterial host defense during murine pneumococcal meningitis. Infect Immun. 2003;71:2276-2279.
224. Mittal R, Gonzalez-Gomez I, Panigrahy A, et al. IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med. 2010;207:1307-1319.
225. Pfister HW, Frei K, Ottnad B, et al. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis. J Exp Med. 1992;176:265-268.
226. Malipiero U, Koedel U, Pfister W, et al. Bacterial meningitis: the role of transforming growth factor-beta in innate immunity and secondary brain damage. Neurodegener Dis. 2007;4:43-50.
227. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39:279-291.
228. Leppert D, Lindberg RL, Kappos L, et al. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev. 2001;36:249-257.
229. Kieseier BC, Paul R, Koedel U, et al. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain. 1999;122:1579-1587.
230. Paul R, Lorenzl S, Koedel U, et al. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol. 1998;44:592-600.
231. Green JA, Thi Hong Chau T, Farrar JJ, et al. CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features. Neurology. 2011;76:577-579.
232. Tsai HC, Shi MH, Lee SS, et al. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis. Clin Microbiol Infect. 2011;17:780-784.
233. Lindberg RL, Sorsa T, Tervahartiala T, et al. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathol Appl Neurobiol. 2006;32:304-317.
234. Sulik A, Chyczewski L. Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis. Folia Histochem Cytobiol. 2008;46:437-442.
235. Leppert D, Leib SL, Grygar C, et al. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis. 2000;31:80-84.
236. Leib SL, Leppert D, Clements J, et al. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infection and Immunity. 2000;68:615-620.
237. Sellner J, Leib SL. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol Dis. 2006;21:647-656.
238. Meli DN, Loeffler JM, Baumann P, et al. In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex. J Neuroimmunol. 2004;151:6-11.
239. Tunkel AR, Scheld WM. Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev. 1993;6:118-136.
240. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care. 1994;9:47-71.
241. Täuber MG, Sande MA. Pathogenesis of bacterial meningitis: contributions by experimental models in rabbits. Infection. 1984;12(suppl 1): S3-S10.
242. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
243. Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678-689.
244. Alon R, Hammer DA, Springer TA. Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature. 1995;374:539-542.
245. Sundd P, Pospieszalska MK, Ley K. Neutrophil rolling at high shear: flattening, catch bond behavior, tethers and slings. Mol Immunol. 2012;55:59-69.
246. Tang T, Frenette PS, Hynes RO, et al. Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J Clin Invest. 1996;97:2485-2490.
247. Granert C, Raud J, Xie X, et al. Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit. J Clin Invest. 1994;93:929-936.
248. Ostergaard C, Yieng-Kow RV, Benfield T, et al. Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun. 2000;68:3153-3157.
249. Brandt CT, Lundgren JD, Frimodt-Moller N, et al. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis. J Neuroimmunol. 2005;166:126-131.
250. Campbell JJ, Qin S, Bacon KB, et al. Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol. 1996;134:255-266.
251. Chan JR, Hyduk SJ, Cybulsky MI. Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J Exp Med. 2001;193:1149-1158.
252. Phillipson M, Heit B, Colarusso P, et al. Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J Exp Med. 2006;203:2569-2575.
253. Bohatschek M, Werner A, Raivich G. Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency. Exp Neurol. 2001;172:137-152.
254. Weber JR, Angstwurm K, Burger W, et al. Anti ICAM-1 (CD 54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J Neuroimmunol. 1995;63:63-68.
255. Saez-Llorens X, Jafari HS, Severien C, et al. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest. 1991;88:2003-2011.
256. Tuomanen EI, Prasad SM, George JS, et al. Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A. 1993;90:7824-7828.
257. Wittchen ES. Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci. 2009;14:2522-2545.
258. von Wedel-Parlow M, Schrot S, Lemmen J, et al. Neutrophils cross the BBB primarily on transcellular pathways: an in vitro study. Brain Res. 2011;1367:62-76.
259. Wilhelm C, Ellner JJ. Chronic meningitis. Neurol Clin. 1986;4:115-141.
260. Cairns H, Russell DS. Cerebral arteritis and phlebitis in pneumococcal meningitis. J Pathol Bacteriol. 1946;58:649-665.
261. Vergouwen MD, Schut ES, Troost D, et al. Diffuse cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis. Neurocrit Care. 2010;13:217-227.
262. Klein M, Koedel U, Pfefferkorn T, et al. Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis. Crit Care. 2011;15:R281.
263. Jan W, Zimmerman RA, Bilaniuk LT, et al. Diffusion-weighted imaging in acute bacterial meningitis in infancy. Neuroradiology. 2003;45:634-639.
264. Takeoka M, Takahashi T. Infectious and inflammatory disorders of the circulatory system and stroke in childhood. Curr Opin Neurol. 2002;15:159-164.
265. Weiss N, Miller F, Cazaubon S, et al. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta. 2009;1788:842-857.
266. Zysk G, Schneider-Wald BK, Hwang JH, et al. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun. 2001;69:845-852.
267. N'Guessan PD, Schmeck B, Ayim A, et al. Streptococcus pneumoniae R6x induced p38 MAPK and JNK-mediated caspase-dependent apoptosis in human endothelial cells. Thromb Haemost. 2005;94:295-303.
268. Bermpohl D, Halle A, Freyer D, et al. Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest. 2005;115:1607-1615.
269. Constantin D, Ala'Aldeent D, Murphy S. Transcriptional activation of nitric oxide synthase-2, and NO-induced cell death, in mouse cerebrovascular endothelium exposed to Neisseria meningitidis. J Neurochem. 2002;81:270-276.
270. Hupp S, Heimeroth V, Wippel C, et al. Astrocytic tissue remodeling by the meningitis neurotoxin pneumolysin facilitates pathogen tissue penetration and produces interstitial brain edema. Glia. 2012;60:137-146.
271. Daneman R. The blood-brain barrier in health and disease. Ann Neurol. 2012;72:648-672.
272. Stamatovic SM, Keep RF, Andjelkovic AV. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol. 2008;6:179-192.
273. Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 2009;1788:864-871.
274. Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol. 2004;190:446-455.
275. Chaitanya GV, Cromer WE, Wells SR, et al. Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro. J Neuroinflammation. 2011;8:162.
276. Forster C, Burek M, Romero IA, et al. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol. 2008;586:1937-1949.
277. Rigor RR, Beard RS Jr, Litovka OP, et al. Interleukin-1beta-induced barrier dysfunction is signaled through PKC-theta in human brain microvascular endothelium. Am J Physiol Cell Physiol. 2012;302: C1513-C1522.
278. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 2009;8:205-216.
279. Koedel U, Bernatowicz A, Paul R, et al. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann Neurol. 1995;37:313-323.
280. Leib SL, Kim YS, Chow LL, et al. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest. 1996;98:2632-2639.
281. Auer M, Pfister LA, Leppert D, et al. Effects of clinically used antioxidants in experimental pneumococcal meningitis. J Infect Dis. 2000;182: 347-350.
282. Mittal R, Gonzalez-Gomez I, Goth KA, et al. Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis. Am J Pathol. 2010;176:1292-1305.
283. Kastenbauer S, Koedel U, Becker BF, et al. Oxidative stress in bacterial meningitis in humans. Neurology. 2002;58:186-191.
284. Koedel U, Pfister HW. Protective effect of the antioxidant N-acetyl-L-cysteine in pneumococcal meningitis in the rat. Neurosci Lett. 1997;225:33-36.
285. Kastenbauer S, Koedel U, Becker BF, et al. Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations. Eur J Pharmacol. 2001;425:149-152.
286. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res. 2009;43:348-364.
287. Koedel U, Pfister HW. Superoxide production by primary rat cerebral endothelial cells in response to pneumococci. J Neuroimmunol. 1999;96:190-200.
288. Caksen H, Cemek M, Dede S, et al. Brief clinical study: lipid peroxidation and antioxidant status in children with acute purulent meningitis and encephalitis. Int J Neurosci. 2004;114:105-111.
289. Lorenzl S, Koedel U, Frei K, et al. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis. J Infect Dis. 1995;172:113-118.
290. Christen S, Schaper M, Lykkesfeldt J, et al. Oxidative stress in brain during experimental bacterial meningitis: differential effects of alpha-phenyl-tert-butyl nitrone and N-acetylcysteine treatment. Free Radic Biol Med. 2001;31:754-762.
291. Paul R, Angele B, Popp B, et al. Differential regulation of blood-brain barrier permeability in brain trauma and pneumococcal meningitis-role of Src kinases. Exp Neurol. 2007;203:158-167.
292. Argaw AT, Asp L, Zhang J, et al. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest. 2012;122:2454-2468.
293. van der Flier M, Coenjaerts FE, Mwinzi PN, et al. Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis. J Neuroimmunol. 2005;160:170-177.
294. Stamatovic SM, Dimitrijevic OB, Keep RF, et al. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl. 2006;96:444-450.
295. Owens HM, Destache CJ, Dash AK. Simple liquid chromatographic method for the analysis of the blood brain barrier permeability characteristics of ceftriaxone in an experimental rabbit meningitis model. J Chromatogr B Biomed Sci Appl. 1999;728:97-105.
296. Leib SL, Kim YS, Black SM, et al. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J Infect Dis. 1998;177:692-700.
297. Lu CH, Chang HW, Lui CC, et al. Cerebral haemodynamics in acute bacterial meningitis in adults. QJM. 2006;99:863-869.
298. Moller K, Qvist T, Tofteng F, et al. Cerebral blood flow and metabolism during infusion of norepinephrine and propofol in patients with bacterial meningitis. Stroke. 2004;35:1333-1339.
299. Ries S, Schminke U, Fassbender K, et al. Cerebrovascular involvement in the acute phase of bacterial meningitis. J Neurol. 1997;244:51-55.
300. Pfister HW, Borasio GD, Dirnagl U, et al. Cerebrovascular complications of bacterial meningitis in adults. Neurology. 1992;42:1497-1504.
301. Pfister HW, Feiden W, Einhaupl KM. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol. 1993;50:575-581.
302. Perry JR, Bilbao JM, Gray T. Fatal basilar vasculopathy complicating bacterial meningitis. Stroke. 1992;23:1175-1178.
303. Ment LR, Ehrenkranz RA, Duncan CC. Bacterial meningitis as an etiology of perinatal cerebral infarction. Pediatr Neurol. 1986;2:276-279.
304. Tureen J, Liu Q, Chow L. Near-infrared spectroscopy in experimental pneumococcal meningitis in the rabbit: cerebral hemodynamics and metabolism. Pediatr Res. 1996;40:759-763.
305. Täuber MG. Brain edema, intracranial pressure and cerebral blood flow in bacterial meningitis. Pediatr Infect Dis J. 1989;8:915-917.
306. Ashwal S, Tomasi L, Schneider S, et al. Bacterial meningitis in children: pathophysiology and treatment. Neurology. 1992;42:739-748.
307. Moller K, Skinhoj P, Knudsen GM, et al. Effect of short-term hyperventilation on cerebral blood flow autoregulation in patients with acute bacterial meningitis. Stroke. 2000;31:1116-1122.
308. Pedersen M, Brandt CT, Knudsen GM, et al. Cerebral blood flow autoregulation in early experimental S. pneumoniae meningitis. J Appl Physiol. 2007;102:72-78.
309. Tureen JH, Dworkin RJ, Kennedy SL, et al. Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J Clin Invest. 1990;85:577-581.
310. Pfister HW, Koedel U, Haberl RL, et al. Microvascular changes during the early phase of experimental bacterial meningitis. J Cereb Blood Flow Metab. 1990;10:914-922.
311. Pfister HW, Koedel U, Dirnagl U, et al. Superoxide dismutase inhibits brain oedema formation in experimental pneumococcal meningitis. Acta Neurochir Suppl (Wien). 1990;51:378-380.
312. Pfister HW, Kodel U, Dirnagl U, et al. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis. J Infect Dis. 1992;166:1442-1445.
313. Hoffmann OM, Becker D, Weber JR. Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis. J Cereb Blood Flow Metab. 2007;27:1792-1797.
314. Schaper M, Gergely S, Lykkesfeldt J, et al. Cerebral vasculature is the major target of oxidative protein alterations in bacterial meningitis. J Neuropathol Exp Neurol. 2002;61:605-613.
315. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140-141:105-112.
316. Kastenbauer S, Koedel U, Becker BF, et al. Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy. Eur J Pharmacol. 2002;449:177-181.
317. Koedel U, Gorriz C, Lorenzl S, et al. Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis. Clin Infect Dis. 1997;25:329-330.
318. Skopal J, Turbucz P, Vastag M, et al. Regulation of endothelin release from human brain microvessel endothelial cells. J Cardiovasc Pharmacol. 1998;31(suppl 1):S370-S372.
319. Sibson NR, Blamire AM, Perry VH, et al. TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin-and TNFR2-dependent pathway. Brain. 2002;125:2446-2459.
320. Sury MD, Frese-Schaper M, Muhlemann MK, et al. Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen-and stress-activated protein kinase. Free Radic Biol Med. 2006;41:1372-1383.
321. Brunner F, Bras-Silva C, Cerdeira AS, et al. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther. 2006;111:508-531.
322. Pfister LA, Tureen JH, Shaw S, et al. Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann Neurol. 2000;47:329-335.
323. Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317-328.
324. Kesser BW, Hashisaki GT, Spindel JH, et al. Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg. 1999;120:628-637.
325. Woolley AL, Kirk KA, Neumann AM Jr, et al. Risk factors for hearing loss from meningitis in children: the Children's Hospital experience. Arch Otolaryngol Head Neck Surg. 1999;125:509-514.
326. Oostenbrink R, Maas M, Moons KG, et al. Sequelae after bacterial meningitis in childhood. Scand J Infect Dis. 2002;34:379-382.
327. Edmond K, Dieye Y, Griffiths UK, et al. Prospective cohort study of disabling sequelae and quality of life in children with bacterial meningitis in urban Senegal. Pediatr Infect Dis J. 2010;29:1023-1029.
328. Adachi N, Ito K, Sakata H. Risk factors for hearing loss after pediatric meningitis in Japan. Ann Otol Rhinol Laryngol. 2010;119:294-296.
329. Douglas SA, Sanli H, Gibson WP. Meningitis resulting in hearing loss and labyrinthitis ossificans-does the causative organism matter? Cochlear Implants Int. 2008;9:90-96.
330. Kutz JW, Simon LM, Chennupati SK, et al. Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg. 2006;132:941-945.
331. Dichgans M, Jager L, Mayer T, et al. Bacterial meningitis in adults: demonstration of inner ear involvement using high-resolution MRI. Neurology. 1999;52:1003-1009.
332. Caye-Thomasen P, Dam MS, Omland SH, et al. Cochlear ossification in patients with profound hearing loss following bacterial meningitis. Acta Otolaryngol. 2012;132:720-725.
333. Nadol JB Jr, Hsu WC. Histopathologic correlation of spiral ganglion cell count and new bone formation in the cochlea following meningogenic labyrinthitis and deafness. Ann Otol Rhinol Laryngol. 1991;100:712-716.
334. Merchant SN, Gopen Q. A human temporal bone study of acute bacterial meningogenic labyrinthitis. Am J Otol. 1996;17:375-385.
335. Klein M, Koedel U, Pfister HW, et al. Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol. 2003;13:123-132.
336. Caye-Thomasen P, Worsoe L, Brandt CT, et al. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis. Laryngoscope. 2009;119:1560-1570.
337. Blank AL, Davis GL, VanDeWater TR, et al. Acute Streptococcus pneumoniae meningogenic labyrinthitis. An experimental guinea pig model and literature review. Arch Otolaryngol Head Neck Surg. 1994;120: 1342-1346.
338. Bhatt S, Halpin C, Hsu W, et al. Hearing loss and pneumococcal meningitis: an animal model. Laryngoscope. 1991;101:1285-1292.
339. Klein M, Koedel U, Kastenbauer S, et al. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment. Infection. 2008;36:2-14.
340. Winter AJ, Comis SD, Osborne MP, et al. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun. 1997;65:4411-4418.
341. Rappaport JM, Bhatt SM, Kimura RS, et al. Electron microscopic temporal bone histopathology in experimental pneumococcal meningitis. Ann Otol Rhinol Laryngol. 1999;108:537-547.
342. Skinner LJ, Beurg M, Mitchell TJ, et al. Intracochlear perfusion of pneumolysin, a pneumococcal protein, rapidly abolishes auditory potentials in the Guinea pig cochlea. Acta Otolaryngol. 2004;124:1000-1007.
343. Brandt CT, Caye-Thomasen P, Lund SP, et al. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis. 2006;23:300-311.
344. Kastenbauer S, Klein M, Koedel U, et al. Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. Brain Res. 2001;904:208-217.
345. Klein M, Koedel U, Pfister HW, et al. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol. 2003;54: 451-458.
346. Ge NN, Brodie HA, Tinling SP. Long-term hearing loss in gerbils with bacterial meningitis treated with superoxide dismutase. Otol Neurotol. 2008;29:1061-1067.
347. Amaee FR, Comis SD, Osborne MP, et al. Possible involvement of nitric oxide in the sensorineural hearing loss of bacterial meningitis. Acta Otolaryngol. 1997;117:329-336.
348. Pai N, Zdanski CJ, Gregory CW, et al. Sodium nitroprusside/nitric oxide causes apoptosis in spiral ganglion cells. Otolaryngol Head Neck Surg. 1998;119:323-330.
349. Jung TT, Llaurado RJ, Nam BH, et al. Effects of nitric oxide on morphology of isolated cochlear outer hair cells: possible involvement in sensorineural hearing loss. Otol Neurotol. 2003;24:682-685.
350. Meli DN, Coimbra RS, Erhart DG, et al. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infection and Immunity. 2006;74:3890-3896.
351. Grandgirard D, Burri M, Agyeman P, et al. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother. 2012;56:4289-4295.
352. Rappaport JM, Bhatt SM, Burkard RF, et al. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac. J Infect Dis. 1999;179:264-268.
353. Worsoe L, Brandt CT, Lund SP, et al. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis. Otol Neurotol. 2010.
354. Kim HH, Addison J, Suh E, et al. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study. Laryngoscope. 2007;117:1209-1215.
355. Coimbra RS, Loquet G, Leib SL. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat. Pediatr Res. 2007;62:291-294.
356. Brouwer MC, McIntyre P, de Gans J, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2010;(9):CD004405.
357. Peltola H, Roine I, Fernandez J, et al. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics. 2010;125:e1-e8.
358. Manolidis S, Johnson R. Do corticosteroids prevent hearing loss in pediatric bacterial meningitis? An analysis of the evidence. Ear Nose Throat J. 2006;85:586-592.
359. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med. 1988;319:964-971.
360. Casella EB, Cypel S, Osmo AA, et al. Sequelae from meningococcal meningitis in children: a critical analysis of dexamethasone therapy. Arq Neuropsiquiatr. 2004;62:421-428.
361. Grimwood K, Nolan TM, Bond L, et al. Risk factors for adverse outcomes of bacterial meningitis. J Paediatr Child Health. 1996;32:457-462.
362. Bedford H, de Louvois J, Halket S, et al. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 2001;323:533-536.
363. Anderson V, Anderson P, Grimwood K, et al. Cognitive and executive function 12 years after childhood bacterial meningitis: effect of acute neurologic complications and age of onset. J Pediatr Psychol. 2004;29:67-81.
364. Schmidt H, Heimann B, Djukic M, et al. Neuropsychological sequelae of bacterial and viral meningitis. Brain. 2006;129:333-345.
365. Grimwood K, Anderson P, Anderson V, et al. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child. 2000;83:111-116.
366. Hoogman M, van de Beek D, Weisfelt M, et al. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry. 2007;78:1092-1096.
367. Focke NK, Kallenberg K, Mohr A, et al. Distributed, limbic gray matter atrophy in patients after bacterial meningitis. AJNR Am J Neuroradiol. 2012.
368. Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012;130:e8-15.
369. Bargui F, D'Agostino I, Mariani-Kurkdjian P, et al. Factors influencing neurological outcome of children with bacterial meningitis at the emergency department. Eur J Pediatr. 2012;171:1365-1371.
370. Berman PH, Banker BQ. Neonatal meningitis. A clinical and pathological study of 29 cases. Pediatrics. 1966;38:6-24.
371. Arseni C, Nereantiu F. Multiple vascular thrombosis with vasculogenic lesions in the course of meningoencephalitis. Confin Neurol. 1972;34:339-347.
372. McDonald R. Purulent meningitis in newborn babies: observations and comments based on a series of 82 patients. Clin Pediatr (Phila). 1972;11:450-454.
373. Erdohazi M. A clinical and pathological study of 43 cases of hydrocephalus not associated with spina bifida. Dev Med Child Neurol Suppl. 1969;20:31-37.
374. Eiben RM. Acute brain swelling (toxic encephalopathy). Pediatr Clin North Am. 1967;14:797-808.
375. Hernandez MI, Sandoval CC, Tapia JL, et al. Stroke patterns in neonatal group B streptococcal meningitis. Pediatr Neurol. 2011;44:282-288.
376. Jorens PG, Parizel PM, Wojciechowski M, et al. Streptococcus pneumoniae meningoencephalitis with unusual and widespread white matter lesions. Eur J Paediatr Neurol. 2008;12:127-132.
377. Shah DK, Daley AJ, Hunt RW, et al. Cerebral white matter injury in the newborn following Escherichia coli meningitis. Eur J Paediatr Neurol. 2005;9:13-17.
378. Täuber MG, Kim YS, Leib SL. Neuronal injury in meningitis. In: Peterson PK, Remington JS, eds. In Defense of the Brain. Malden, MA: Blackwell Science; 1997:124-143.
379. Nau R, Gerber J, Bunkowski S, et al. Axonal injury, a neglected cause of CNS damage in bacterial meningitis. Neurology. 2004;62:509-511.
380. Gerber J, Seitz RC, Bunkowski S, et al. Evidence for frequent focal and diffuse acute axonal injury in human bacterial meningitis. Clin Neuropathol. 2009;28:33-39.
381. Renier D, Flandin C, Hirsch E, et al. Brain abscesses in neonates. A study of 30 cases. J Neurosurg. 1988;69:877-882.
382. Cone LA, Leung MM, Byrd RG, et al. Multiple cerebral abscesses because of Listeria monocytogenes: three case reports and a literature review of supratentorial listerial brain abscess(es). Surg Neurol. 2003;59:320-328.
383. Zysk G, Bruck W, Gerber J, et al. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol. 1996;55:722-728.
384. Bifrare YD, Gianinazzi C, Imboden H, et al. Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats. Hippocampus. 2003;13:481-488.
385. Gianinazzi C, Grandgirard D, Imboden H, et al. Caspase-3 mediates hippocampal apoptosis in pneumococcal meningitis. Acta Neuropathol. 2003;105:499-507.
386. Braun JS, Novak R, Herzog KH, et al. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med. 1999;5:298-302.
387. Loeffler JM, Ringer R, Hablutzel M, et al. The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. The Journal of Infectious Diseases. 2001;183:247-252.
388. Wellmer A, Noeske C, Gerber J, et al. Spatial memory and learning deficits after experimental pneumococcal meningitis in mice. Neurosci Lett. 2000;296:137-140.
389. Grandgirard D, Bifrare YD, Pleasure SJ, et al. Pneumococcal meningitis induces apoptosis in recently postmitotic immature neurons in the dentate gyrus of neonatal rats. Dev Neurosci. 2007;29:134-142.
390. Leib SL, Heimgartner C, Bifrare YD, et al. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatric research. 2003;54:353-357.
391. Hofer S, Grandgirard D, Burri D, et al. Bacterial meningitis impairs hippocampal neurogenesis. J Neuropathol Exp Neurol. 2011;70:890-899.
392. Liebetanz D, Gerber J, Schiffner C, et al. Pre-infection physical exercise decreases mortality and stimulates neurogenesis in bacterial meningitis. J Neuroinflammation. 2012;9:168.
393. Tauber SC, Stadelmann C, Spreer A, et al. Increased expression of BDNF and proliferation of dentate granule cells after bacterial meningitis. J Neuropathol Exp Neurol. 2005;64:806-815.
394. Gerber J, Bottcher T, Bering J, et al. Increased neurogenesis after experimental Streptococcus pneumoniae meningitis. J Neurosci Res. 2003;73:441-446.
395. Wittwer M, Grandgirard D, Rohrbach J, et al. Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis. BMC Infect Dis. 2010;10:176.
396. Nau R, Soto A, Bruck W. Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol. 1999;58:265-274.
397. Free SL, Li LM, Fish DR, et al. Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis. Epilepsia. 1996;37:400-405.
398. Gerber J, Tauber SC, Armbrecht I, et al. Increased neuronal proliferation in human bacterial meningitis. Neurology. 2009;73:1026-1032.
399. Coimbra RS, Voisin V, de Saizieu AB, et al. Gene expression in cortex and hippocampus during acute pneumococcal meningitis. BMC Biol. 2006;4:15.
400. Braun JS, Novak R, Murray PJ, et al. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis. 2001;184:1300-1309.
401. Thal SE, Zhu C, Thal SC, et al. Role of apoptosis inducing factor (AIF) for hippocampal neuronal cell death following global cerebral ischemia in mice. Neurosci Lett. 2011;499:1-3.
402. Mitchell L, Smith SH, Braun JS, et al. Dual phases of apoptosis in pneumococcal meningitis. J Infect Dis. 2004;190:2039-2046.
403. Chan PH, Fishman RA, Wesley MA, et al. Pathogenesis of vasogenic edema in focal cerebral ischemia. Role of superoxide radicals. Adv Neurol. 1990;52:177-183.
404. Nag S, Manias JL, Stewart DJ. Pathology and new players in the pathogenesis of brain edema. Acta Neuropathol. 2009;118:197-217.
405. Derugin N, Wendland M, Muramatsu K, et al. Evolution of brain injury after transient middle cerebral artery occlusion in neonatal rats. Stroke. 2000;31:1752-1761.
406. Leib SL, Kim YS, Ferriero DM, et al. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J Infect Dis. 1996;173:166-171.
407. Scheld WM, Dacey RG, Winn HR, et al. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest. 1980;66:243-253.
408. Del Bigio MR. Neuropathological changes caused by hydrocephalus. Acta Neuropathol. 1993;85:573-585.
409. Kaplan SL, Feigin RD. The syndrome of inappropriate secretion of antidiuretic hormone in children with bacterial meningitis. J Pediatr. 1978;92:758-761.
410. Winkler F, Kastenbauer S, Yousry TA, et al. Discrepancies between brain CT imaging and severely raised intracranial pressure proven by ventriculostomy in adults with pneumococcal meningitis. J Neurol. 2002;249:1292-1297.
411. Lindvall P, Ahlm C, Ericsson M, et al. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis. 2004;38:384-390.
412. Fishman RA. Brain edema. N Engl J Med. 1975;293:706-711.
413. Brown LW, Feigin RD. Bacterial meningitis: fluid balance and therapy. Pediatr Ann. 1994;23:93-98.
414. Agre P, King LS, Yasui M, et al. Aquaporin water channels-from atomic structure to clinical medicine. J Physiol. 2002;542:3-16.
415. Arcienega, II, Brunet JF, Bloch J, et al. Cell locations for AQP1, AQP4 and 9 in the non-human primate brain. Neuroscience. 2010;167:1103-1114.
416. Saadoun S, Papadopoulos MC. Aquaporin-4 in brain and spinal cord oedema. Neuroscience. 2010;168:1036-1046.
417. Papadopoulos MC, Verkman AS. Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis. J Biol Chem. 2005;280:13906-13912.
418. Saadoun S, Papadopoulos MC, Krishna S. Water transport becomes uncoupled from K+ siphoning in brain contusion, bacterial meningitis, and brain tumours: immunohistochemical case review. J Clin Pathol. 2003;56:972-975.
419. Blocher J, Eckert I, Elster J, et al. Aquaporins AQP1 and AQP4 in the cerebrospinal fluid of bacterial meningitis patients. Neurosci Lett. 2011;504:23-27.
420. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345:1727-1733.
421. McMillan DA, Lin CY, Aronin SI, et al. Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis. 2001;33:969-975.
422. Sugiyama K, Brunori A, Mayer ML. Glial uptake of excitatory amino acids influences neuronal survival in cultures of mouse hippocampus. Neuroscience. 1989;32:779-791.
423. Spranger M, Krempien S, Schwab S, et al. Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J Neurol Sci. 1996;143:126-131.
424. Guerra-Romero L, Tauber MG, Fournier MA, et al. Lactate and glucose concentrations in brain interstitial fluid, cerebrospinal fluid, and serum during experimental pneumococcal meningitis. J Infect Dis. 1992;166:546-550.
425. Sellner J, Ringer R, Baumann P, et al. Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitis. Curr Drug Metab. 2008;9:83-88.
426. Bellac CL, Coimbra RS, Christen S, et al. Inhibition of the kynurenine-NAD+ pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis. J Neuropathol Exp Neurol. 2010;69: 1096-1104.
427. Grandgirard D, Leib SL. Meningitis in neonates: bench to bedside. Clin Perinatol. 2010;37:655-676.
428. Recher M, Malipiero U, Schaer DJ, et al. Inhibition of meningitis-associated neutrophil apoptosis by TNF-alpha depends on functional PI3-kinase in monocytes. J Leukoc Biol. 2013;93:259-266.
429. Tunbridge AJ, Stevanin TM, Lee M, et al. Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms. Infect Immun. 2006;74:729-733.
430. Wennekamp J, Henneke P. Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev. 2008;225: 114-127.
431. Koedel U, Frankenberg T, Kirschnek S, et al. Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog. 2009;5:e1000461.
432. Nguyen HX, O'Barr TJ, Anderson AJ. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J Neurochem. 2007;102:900-912.
433. Carney JM, Starke-Reed PE, Oliver CN, et al. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci U S A. 1991;88:3633-3636.
434. Klein M, Koedel U, Pfister HW. Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? Prog Neurobiol. 2006;80:269-280.
435. Spranger M, Schwab S, Krempien S, et al. Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch Neurol. 1996;53:992-996.
436. Ghielmetti M, Ren H, Leib SL, et al. Impaired cortical energy metabolism but not major antioxidant defenses in experimental bacterial meningitis. Brain Res. 2003;976:139-148.
437. Simon RP, Beckman JS. Why pus is bad for the brain. Neurology. 2002;58:167-168.
438. Braun J. Inducible nitric oxide synthase mediates hippocampal caspase-3 activation in pneumococcal meningitis. Int J Neurosci. 2009;119: 455-459.
439. Guo Z, Sun X, He Z, et al. Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage. Neurol Sci. 2010;31:143-149.
440. Murase S, McKay RD. Matrix metalloproteinase-9 regulates survival of neurons in newborn hippocampus. J Biol Chem. 2012;287: 12184-12194.
441. Fujita-Hamabe W, Tokuyama S. The involvement of cleavage of neural cell adhesion molecule in neuronal death under oxidative stress conditions in cultured cortical neurons. Biol Pharm Bull. 2012;35:624-628.
442. Braun JS, Sublett JE, Freyer D, et al. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest. 2002;109:19-27.
443. Braun JS, Hoffmann O, Schickhaus M, et al. Pneumolysin causes neuronal cell death through mitochondrial damage. Infect Immun. 2007;75: 4245-4254.
444. Beurg M, Hafidi A, Skinner L, et al. The mechanism of pneumolysin-induced cochlear hair cell death in the rat. J Physiol. 2005;568:211-227.
445. Reiss A, Braun JS, Jager K, et al. Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis. J Infect Dis. 2011;203:393-400.
446. Ostergaard C, Leib SL, Rowland I, et al. Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis. BMC Infect Dis. 2010;10:1.